Really all the estimates for sales, profit and share price are totally dependent on the company's estimates of production capacity and total sales revenue. It looks to me like the various delays in testing, approvals, consents and commissioning have already added up to 12-18 months. Edenplast could increase sales revenue and forecasts, but its not clear how far away that is from commercialisation.
At the moment the challenge as I see it is to get sufficient sales revenue to justify proceeding with the Georgia plant and completing the employment provisions so as to comply with the agreement. 2023 might seem far away now, but my experience is that time passes quickly on big projects and 18m of buffer has already been eroded.
Really all the estimates for sales, profit and share price are...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EDE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.216M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $8 | 3.965K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 125568442 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 21203859 | 29 |
View Market Depth
| Last trade - 10.02am 27/09/2024 (20 minute delay) ? |
| EDE (ASX) Chart |